Literature DB >> 14658933

Symptoms of fatigue and cognitive/executive dysfunction in major depressive disorder before and after antidepressant treatment.

Maurizio Fava1.   

Abstract

Patients with major depressive disorder commonly experience fatigue and cognitive/executive dysfunction. These problems may be symptoms of the depression and persist despite effective antidepressant treatment, or these problems may emerge as adverse effects of some antidepressant treatments. A number of augmentation strategies can be employed to manage fatigue or cognitive/executive dysfunction, but the efficacy of these augmentation strategies must be researched further.

Entities:  

Mesh:

Year:  2003        PMID: 14658933

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  24 in total

1.  Fatigue as a residual symptom of depression.

Authors:  Steven D Targum; Maurizio Fava
Journal:  Innov Clin Neurosci       Date:  2011-10

2.  Managing depression in primary care: achieving remission.

Authors: 
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2006

3.  Lower brain-derived neurotrophic factor levels associated with worsening fatigue in prostate cancer patients during repeated stress from radiation therapy.

Authors:  L N Saligan; N Lukkahatai; G Holder; B Walitt; R Machado-Vieira
Journal:  World J Biol Psychiatry       Date:  2015-03-27       Impact factor: 4.132

4.  Low-dose transdermal testosterone augmentation therapy improves depression severity in women.

Authors:  Karen K Miller; Roy H Perlis; George I Papakostas; David Mischoulon; Dan V Losifescu; Danielle J Brick; Maurizio Fava
Journal:  CNS Spectr       Date:  2009-12       Impact factor: 3.790

5.  A review of executive function deficits and pharmacological management in children and adolescents.

Authors:  Sheik Hosenbocus; Raj Chahal
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2012-08

6.  Cortical abnormalities and association with symptom dimensions across the depressive spectrum.

Authors:  Marc S Lener; Prantik Kundu; Edmund Wong; Kaitlin E Dewilde; Cheuk Y Tang; Priti Balchandani; James W Murrough
Journal:  J Affect Disord       Date:  2015-10-30       Impact factor: 4.839

7.  Development of a clinician-administered National Institutes of Health-Brief Fatigue Inventory: A measure of fatigue in the context of depressive disorders.

Authors:  Leorey N Saligan; David A Luckenbaugh; Elizabeth E Slonena; Rodrigo Machado-Vieira; Carlos A Zarate
Journal:  J Psychiatr Res       Date:  2015-06-24       Impact factor: 4.791

8.  Cognitive performance in depressed patients after chronic use of antidepressants.

Authors:  Clarice Gorenstein; Stefania Caldeira de Carvalho; Rinaldo Artes; Ricardo Alberto Moreno; Tania Marcourakis
Journal:  Psychopharmacology (Berl)       Date:  2006-02-17       Impact factor: 4.530

Review 9.  Antidepressants and Cdk inhibitors: releasing the brake on neurogenesis?

Authors:  Vera Chesnokova; Robert N Pechnick
Journal:  Cell Cycle       Date:  2008-06-17       Impact factor: 4.534

10.  Biopsychosocial predictors of fatigue in quiescent and mild ulcerative colitis - an explorative study.

Authors:  Winfried Häuser; Andreas Stallmach; Rueya-Daniela Kocalevent; Matthias Rose; Herbert Fliege
Journal:  Psychosoc Med       Date:  2005-06-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.